Lv6
2337 积分 2025-03-14 加入
LBA4 WES-powered MRD navigation for adjuvant therapy in hepatocellular carcinoma
8天前
已完结
Apatinib inhibits gastric cancer progression by inducing ferroptosis through cysteine dioxygenase 1/phosphoinositide 3-kinase/Akt axis
9天前
已完结
Non-kinase Orchestrated VEGFR2-ERK Signaling is a Dependency and Pharmacological Target for Antiangiogenic Immunotherapy
9天前
已完结
Dalpiciclib plus endocrine therapy in women with HR+/HER2− advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial
9天前
已完结
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
10天前
已完结
Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial
13天前
已完结
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
14天前
已完结
Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan
16天前
已完结
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer
20天前
已完结
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer
20天前
已关闭
A 66-Year-Old Woman Found Unresponsive
6天前
已采纳
理性看待PCOS更名 优化本土术语实践PCOS更名为PMOS的科学思辨
6天前
已采纳
儿童非食管嗜酸细胞性胃肠疾病的诊治管理：欧美共识指南的解读
6天前
已采纳
含乌头类口服中成药说明书中的安全性内容分析
6天前
已采纳
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
21天前
已采纳
皖公网安备34019202002308
